Your browser doesn't support javascript.
loading
The Role of CXCL13 and CXCL9 in Early Breast Cancer.
Razis, Evangelia; Kalogeras, Konstantine T; Kotsantis, Ioannis; Koliou, Georgia-Angeliki; Manousou, Kyriaki; Wirtz, Ralph; Veltrup, Elke; Patsea, Helen; Poulakaki, Nikiforita; Dionysopoulos, Dimitrios; Pervana, Stavroula; Gogas, Helen; Koutras, Angelos; Pentheroudakis, George; Christodoulou, Christos; Linardou, Helena; Pavlakis, Kitty; Koletsa, Triantafyllia; Pectasides, Dimitrios; Zagouri, Flora; Fountzilas, George.
Afiliação
  • Razis E; Third Department of Medical Oncology, Hygeia Hospital, Athens, Greece. Electronic address: e.razis@hygeia.gr.
  • Kalogeras KT; Translational Research Section, Hellenic Cooperative Oncology Group, Athens, Greece; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Kotsantis I; Section of Medical Oncology, Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Koliou GA; Section of Biostatistics, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece.
  • Manousou K; Section of Biostatistics, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece.
  • Wirtz R; STRATIFYER Molecular Pathology GmbH, Cologne, Germany.
  • Veltrup E; STRATIFYER Molecular Pathology GmbH, Cologne, Germany.
  • Patsea H; Department of Pathology, IASSO General Hospital, Athens, Greece.
  • Poulakaki N; Breast Surgery Clinic, Euroclinic, Athens, Greece.
  • Dionysopoulos D; Department of Medical Oncology, Papageorgiou Hospital, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece.
  • Pervana S; Department of Pathology, Papageorgiou Hospital, Thessaloniki, Greece.
  • Gogas H; First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Koutras A; Division of Oncology, Department of Medicine, University Hospital, University of Patras Medical School, Patras, Greece.
  • Pentheroudakis G; Department of Medical Oncology, Ioannina University Hospital, Ioannina, Greece.
  • Christodoulou C; Second Department of Medical Oncology, Metropolitan Hospital, Piraeus, Greece.
  • Linardou H; Oncology Unit, Metropolitan Hospital, Piraeus, Greece.
  • Pavlakis K; Pathology Department, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Koletsa T; Department of Pathology, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece.
  • Pectasides D; Oncology Section, Second Department of Internal Medicine, Hippokration Hospital, Athens, Greece.
  • Zagouri F; Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Fountzilas G; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece; Aristotle University of Thessaloniki, Thessaloniki, Greece.
Clin Breast Cancer ; 20(1): e36-e53, 2020 02.
Article em En | MEDLINE | ID: mdl-31699671
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Linfócitos do Interstício Tumoral / Quimiocina CXCL9 / Quimiocina CXCL13 Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Linfócitos do Interstício Tumoral / Quimiocina CXCL9 / Quimiocina CXCL13 Idioma: En Ano de publicação: 2020 Tipo de documento: Article